Tamiflu: the battle for key drug data. Influenza medication oseltamivir has made billions

Tamiflu: the battle for key drug data. Influenza medication oseltamivir has made billions The CDC article maintained that reviews of randomised trials that are controlled maybe not fully notify issue of whether antiviral therapy reduces serious problems of influenza. It is additionally maintained that “reviews of RCTs . . . have discovered consistent medical good… Continue reading Tamiflu: the battle for key drug data. Influenza medication oseltamivir has made billions